A growing appetite exists within the pharmaceutical industry for AI to deliver instant results like manuscripts and insights. This "magic button" expectation overlooks the nuance required, forcing communication experts to manage expectations and emphasize AI's role as a human-augmenting tool, not a replacement.

Despite AI's power, it cannot replace the human element of data analysis, which requires stakeholder management, domain knowledge, and critical thinking to validate results. An AI can produce errors, making human judgment more crucial than ever to avoid costly mistakes and provide true insights.

A major risk of AI is reps will "outsource human judgment," losing the intuition that defines top performers. The correct mental model is to treat AI as a "thought partner"—a tool to accelerate research and test ideas, while the human remains responsible for strategic decisions.

As doctors integrate AI into their work (e.g., ambient scribing), they expect more from their partners. MedTech sales reps can no longer rely solely on relationships; they must provide data-backed, highly personalized insights to be valuable.

AI models fail in business applications because they lack the specific context of an organization's operations. Siloed data from sales, marketing, and service leads to disconnected and irrelevant AI-driven actions, making agents seem ineffective despite their power. Unified data provides the necessary 'corporate intelligence'.

The primary danger of AI in product management isn't technical failure but the abdication of critical thinking. Over-relying on AI summaries of user feedback means missing the crucial 'color' and context. Leaders risk losing their direct connection to the customer's voice by outsourcing their thinking to an LLM.

Off-the-shelf AI models can only go so far. The true bottleneck for enterprise adoption is "digitizing judgment"—capturing the unique, context-specific expertise of employees within that company. A document's meaning can change entirely from one company to another, requiring internal labeling.

Despite AI's capabilities, it lacks the full context necessary for nuanced business decisions. The most valuable work happens when people with diverse perspectives convene to solve problems, leveraging a collective understanding that AI cannot access. Technology should augment this, not replace it.

Data can be misleading without context. True strategic intelligence integrates quantitative data (e.g., clinical trial results) with human intelligence (e.g., observing audience reactions at a conference). This contextual layer reveals market sentiment and believability that numbers alone cannot provide.